SOURCE: Glycology, Inc.

October 12, 2005 06:53 ET

Glycology, Inc. Announces Its Dealer Direct Program for Celsync™, the First All-Natural Nutrient, Based on Nobel Prize Science

PHILADELPHIA, PA -- (MARKET WIRE) -- October 12, 2005 -- Glycology, Inc. (OTC: GYLG) (, the producer of Celsync™ (, the first all-natural nutrient, based on recent Noble Prize winning research (1994, 1999, 2000 and 2001) that identified cell-to-cell communications as the key to slowing the aging process, improving performance and inhibiting disease, announced its dealer direct program.

Celsync™, which is the first product to capitalize on the new science of glycobiology, is provided in 90-capsule bottles, taken one capsule three times a day. It is neither a vitamin nor a mineral, but rather an all-natural botanical that has documented healing properties coupled with the ability to enhance the positive effects of multi-vitamins and minerals.

"As soon as we introduced Celsync™, an extraordinary number of dealers wanted to sell it," said Donna Murdoch, Glycology president. "We have now decided to market it directly to individual dealers and provide them with pricing equal to chain stores and distributors. We want a level playing field where smaller dealers can compete with larger chains and distributors."

Dealers, such as health and natural food stores, pharmacies, vitamin specialty shops, health clubs and general retail locations, are invited to join its dealer direct program and sign up online at ( Among other features, its dealer direct program offers attractive margins, and annual cash rebates.

About Glycology, Inc.

Glycology, Inc. ( is a lifesciences company focused on the discovery, development and marketing of nutraceutical preparations and supplements that enhance health, and well being, as well as prevent and treat a broad range of illnesses. Its flagship product, Celsync™ (, is a breakthrough dietary supplement based on Nobel Prize winning research. Glycology, Inc., is the first company to capitalize on these amazing scientific breakthroughs by commercializing Celsync™ and expects to release additional products including Celsync™-based health and beauty products, as well as veterinary food supplements.

Forward-Looking Statements:

With the exception of historical information, this news release and accompanying information may include forward-looking statements that involve a number of risks and uncertainties. Actual results could differ materially from those anticipated as a result of various risks. There are numerous factors that could contribute to such differences, therefore such projected events and anticipated results are not warranties or guaranties that such events will occur or that the Company will achieve such results. For more information about this corporation and risks involved in the investment of their publicly traded shares, please see the company's website(s), and/or documents filed with the SEC, which are easily accessible in the EDGAR database system.

Contact Information